Literature DB >> 25262533

Disease modeling in functional movement disorders.

Roberta Pellicciari1, Maria Superbo1, Angelo Fabio Gigante1, Paolo Livrea1, Giovanni Defazio2.   

Abstract

INTRODUCTION: The mechanisms underlying functional movement disorders are poorly known. We examined whether experience of a movement disorder model in the family and/or the friendships contributes to functional movement disorders.
METHODS: The hypothesis was tested in a case-control study including 33 patients with functional movement disorders and 66 age- and sex-matched patients with organic movement disorders and using a conditional logistic multivariable analysis (adjusted by age, education, disease duration, chronic medical illnesses and clinical phenotype).
RESULTS: Case-control comparison yielded a significant association between functional movement disorders and exposure to phenotypically congruent movement disorder models (Odds ratio, 3.9, p = 0.01), mainly when disease model came from friendships (Odds ratio, 5.9, p = 0.04). By contrast no association was found between functional movement disorders and phenotypically different neurological or non neurological disease models. A significant inverse relationship between exposure to a phenotypically concordant movement disorder model and age of disease onset was also observed.
CONCLUSIONS: These findings support disease modeling as a factor contributing to the phenomenology of functional movement disorders.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Disease model; Functional; Movement disorder; Psychogenic

Mesh:

Year:  2014        PMID: 25262533     DOI: 10.1016/j.parkreldis.2014.09.017

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  8 in total

Review 1.  Psychogenic nonepileptic seizures and movement disorders: A comparative review.

Authors:  Roberto Erro; Francesco Brigo; Eugen Trinka; Giulia Turri; Mark J Edwards; Michele Tinazzi
Journal:  Neurol Clin Pract       Date:  2016-04

2.  Functional (psychogenic) stereotypies.

Authors:  José Fidel Baizabal-Carvallo; Joseph Jankovic
Journal:  J Neurol       Date:  2017-06-26       Impact factor: 4.849

3.  Tics and TikTok: Functional Tics Spread Through Social Media.

Authors:  Mariam Hull; Mered Parnes
Journal:  Mov Disord Clin Pract       Date:  2021-07-01

4.  Functional Motor Disorders Mimicking Symptoms Upon Resolution of Cerebrovascular Disease.

Authors:  Fabio Paio; Elena Antelmi; Enrico Conti; Ilaria Di Vico; Michele Tinazzi
Journal:  Mov Disord Clin Pract       Date:  2020-05-31

Review 5.  A dimensional approach to functional movement disorders: Heresy or opportunity.

Authors:  Primavera A Spagnolo; Marjorie Garvey; Mark Hallett
Journal:  Neurosci Biobehav Rev       Date:  2021-04-10       Impact factor: 9.052

6.  Recognizing uncommon presentations of psychogenic (functional) movement disorders.

Authors:  José Fidel Baizabal-Carvallo; Robert Fekete
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-01-21

7.  Functional motor phenotypes: to lump or to split?

Authors:  Michele Tinazzi; Christian Geroin; Enrico Marcuzzo; Sofia Cuoco; Roberto Ceravolo; Sonia Mazzucchi; Andrea Pilotto; Alessandro Padovani; Luigi Michele Romito; Roberto Eleopra; Mario Zappia; Alessandra Nicoletti; Carlo Dallocchio; Carla Arbasino; Francesco Bono; Giuseppe Magro; Benedetta Demartini; Orsola Gambini; Nicola Modugno; Enrica Olivola; Laura Bonanni; Elisabetta Zanolin; Alberto Albanese; Gina Ferrazzano; Rosa De Micco; Leonardo Lopiano; Giovanna Calandra-Buonaura; Martina Petracca; Marcello Esposito; Antonio Pisani; Paolo Manganotti; Lucia Tesolin; Francesco Teatini; Tommaso Ercoli; Francesca Morgante; Roberto Erro
Journal:  J Neurol       Date:  2021-05-07       Impact factor: 4.849

8.  Functional neurological disorder after COVID-19 vaccination.

Authors:  Tommaso Ercoli; Laura Lutzoni; Gianni Orofino; Antonella Muroni; Giovanni Defazio
Journal:  Neurol Sci       Date:  2021-07-29       Impact factor: 3.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.